Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Feasibility Device Study to Prevent Female Urinary Stress Incontinence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03010800
Recruitment Status : Completed
First Posted : January 5, 2017
Results First Posted : November 6, 2017
Last Update Posted : January 18, 2018
Sponsor:
Collaborator:
University of Oklahoma
Information provided by (Responsible Party):
Watkins Conti Products. Inc.

Tracking Information
First Submitted Date  ICMJE December 27, 2016
First Posted Date  ICMJE January 5, 2017
Results First Submitted Date  ICMJE May 8, 2017
Results First Posted Date  ICMJE November 6, 2017
Last Update Posted Date January 18, 2018
Actual Study Start Date  ICMJE January 4, 2017
Actual Primary Completion Date February 28, 2017   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: October 5, 2017)
Pad Weight Difference [ Time Frame: An hour after finishing a liter of liquid ]
Comparison of urine weight of the pad without Yoni,Fit to the weight of the pad with Yoni.Fit controlling for the tare weight.
Original Primary Outcome Measures  ICMJE
 (submitted: January 3, 2017)
Change in Pad Test Score [ Time Frame: An hour after finishing a liter of liquid ]
Change in Pad Test score is the weight of the pad worn without the device in place minus the tare weight of the pad divided by the weight of the pad with the device in place minus the tare weight of the pad.
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE A Feasibility Device Study to Prevent Female Urinary Stress Incontinence
Official Title  ICMJE Randomized, Crossover Feasibility Study of a Device to Prevent Female Urinary Stress Incontinence
Brief Summary This study will test the acute efficacy of an investigational device (Yoni.Fit) in a clinical trial of women with incontinence in a standardized set of challenges performed with and without the device in place.
Detailed Description
  1. Potential subjects will be pre-qualified by a 6-item questionnaire, the validated Questionnaire for Urinary Incontinence Diagnosis (QUID). This questionnaire has 3 questions each referring to the seriousness of Stress Urinary Incontinence (SUI) and of Urge Urinary Incontinence (UUI). Subjects will be accepted if their SUI score is 5 or greater and is greater than the UUI score. For privacy reasons, these scores will not be retained. Subjects will then be given an appointment. Subjects will be instructed to wear comfortable athletic type wear and not to drink any fluid for two hours prior to their appointment.
  2. When subjects appear for their appointment, subjects will be administered the informed consent by the Study Coordinator. All paperwork will be pre-numbered with a code that will link to the subject name. The key will be kept confidential by the Study Coordinator. They will be instructed to empty their bladders and will be given a liter of water or other drink and instructed to drink it over a 15-20 minute time period. An abbreviated patient history will be obtained for the purpose of establishing whether the subject meets the inclusion criteria and is not disqualified by meeting the exclusion criteria. The subject will again fill out the QUID questionnaire. The inclusion criteria are a SUI score of 5 or greater, predominately SUI (SUI score>UUI score) and age between 25 and 65. Exclusion criteria are predominantly UUI, prolapse greater than mild, hysterectomy or other pelvic floor surgery other than a Caesarian section, diabetes, pregnant, BMI>35 or unable to perform ten "jumping jack" exercises. Patients will be administered three additional questionnaires in order to compute a Severity Score. These questionnaires are the Urinary Distress Inventory (UDI), Urinary Impact Questionnaire (UIQ) and the Incontinence Severity Index (ISI). The scores will be multiplied together to provide the Severity Score.
  3. Patients will be randomized to Group A or Group B to participate in an abbreviated Pad Test. Group A will perform the test with the Yoni.Fit device in place then repeat the test without the device. Group B will perform the test without the Yoni.Fit device in place then repeat the test with the device in place. This test has been validated (5). An hour after finishing the liter of liquid, the subject is given a tared incontinence pad, which is then put in place. She then engages in the following mild exercise challenges..

    1. Stand from sitting 10 times.
    2. Cough vigorously while standing.
    3. Bend down to pick up small object.
    4. Perform ten jumping jacks. The subject then will remove pad, place into bag and seal. The Experimenter will then weigh pad. The subjects will be randomized so that half will perform the Abbreviated Pad Test with the Yoni.Fit device in place followed by repeating without the device in place. The other half will perform the challenges in the reverse order.
  4. The experimenter will calculate a change in score, which is the weight of the pad worn without the device in place minus the tare weight of the pad divided by the weight of the pad with the device in place minus the tare weight of the pad. In case no urine is released with the device in place, the Improvement Score will be defined as "1000". A Release Change will also be calculated as the net weight without the device in place minus the weight with the device in place divided by the net weight released without the device in place.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Condition  ICMJE Stress Incontinence, Female
Intervention  ICMJE
  • Device: With Yoni.Fit
    Abbreviated Pad Test with Yoni.Fit first, then without Yoni.Fit.
  • Device: Without Yoni.Fit
    Abbreviated Pad Test without Yoni.Fit, then with Yoni.Fit.
Study Arms  ICMJE
  • Experimental: With Yoni.Fit
    Subjects will perform the Abbreviated Pad Test with the Yoni.Fit first, then without the Yoni.Fit.
    Intervention: Device: With Yoni.Fit
  • Experimental: Without Yoni.Fit
    Subjects will perform the Abbreviated Pad Test without the Yoni.Fit first, then with the Yoni.Fit.
    Intervention: Device: Without Yoni.Fit
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: October 5, 2017)
8
Original Estimated Enrollment  ICMJE
 (submitted: January 3, 2017)
50
Actual Study Completion Date  ICMJE May 3, 2017
Actual Primary Completion Date February 28, 2017   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Urinary Incontinence Diagnosis (QUID). This questionnaire has 3 questions each referring to the seriousness of Stress Urinary Incontinence (SUI) and of Urge Urinary Incontinence (UUI). Subjects will be accepted if their SUI score is 5 or greater and is greater than the UUI score.

Exclusion Criteria:

  • Refusal to sign the informed consent document
  • SUI score is less than 5 or is less than the UUI score.
  • Predominantly UUI
  • Prolapse greater than mild
  • Hysterectomy or other pelvic floor surgery other than a Caesarian section
  • Diabetes,
  • Pregnant,
  • BMI>35 or unable to perform ten "jumping jack" exercises.
Sex/Gender  ICMJE
Sexes Eligible for Study: Female
Ages  ICMJE 25 Years to 65 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03010800
Other Study ID Numbers  ICMJE WCP001
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE
Plan to Share IPD: Undecided
Responsible Party Watkins Conti Products. Inc.
Study Sponsor  ICMJE Watkins Conti Products. Inc.
Collaborators  ICMJE University of Oklahoma
Investigators  ICMJE Not Provided
PRS Account Watkins Conti Products. Inc.
Verification Date June 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP